In addition, a recent study indicated that blocking TLR4 could effectively attenuate monoiodoacetate-induced arthritis in rats by relieving joint pain and reducing the expression of TNF-α, IL-1β, and matrix metallopeptidase-13 (MMP13) [65]. Here, IL1B is linked to arthritic joint disease.